These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9050794)

  • 21. Synthesis of NO-donor bisphosphonates and their in-vitro action on bone resorption.
    Lazzarato L; Rolando B; Lolli ML; Tron GC; Fruttero R; Gasco A; Deleide G; Guenther HL
    J Med Chem; 2005 Mar; 48(5):1322-9. PubMed ID: 15743175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo.
    Fournier PG; Daubiné F; Lundy MW; Rogers MJ; Ebetino FH; Clézardin P
    Cancer Res; 2008 Nov; 68(21):8945-53. PubMed ID: 18974139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.
    Juraschek M; Seibel MJ; Woitge HW; Krempien B; Bauss F
    Bone; 2000 May; 26(5):475-83. PubMed ID: 10773587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diphosphonates in the treatment of bone metastases].
    Jung A; Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.
    Ohba T; Cole HA; Cates JM; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
    J Bone Miner Res; 2014 Jun; 29(6):1431-45. PubMed ID: 24443409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
    Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
    Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
    J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition by two diphosphonates of bone lysis in tumor-conditioned media.
    Jung A; Mermillod B; Barras C; Baud M; Courvoisier B
    Cancer Res; 1981 Aug; 41(8):3233-7. PubMed ID: 6454481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice.
    Nemoto R; Satou S; Miyagawa I; Koiso K
    Cancer; 1991 Feb; 67(3):643-8. PubMed ID: 1898709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of bisphosphonate activity in vitro.
    Mitrofan LM; Auriola S; Mönkkönen H; Mönkkönen J
    Curr Pharm Des; 2010; 16(27):2970-80. PubMed ID: 20722618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
    Yaghoobian J; Morieux C; Denne MA; Bouizar Z; Ureña P; de Vernejoul MC
    Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256.
    Krempien B; Wingen F; Eichmann T; Müller M; Schmähl D
    Oncology; 1988; 45(1):41-6. PubMed ID: 3340393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis.
    Huk OL; Zukor DJ; Antoniou J; Petit A
    J Orthop Res; 2003 Jan; 21(1):81-7. PubMed ID: 12507583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages.
    Stevenson PH; Stevenson JR
    Calcif Tissue Int; 1986 Apr; 38(4):227-33. PubMed ID: 3085901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diphosphonates inhibit bone resorption by macrophages in vitro.
    Chambers TJ
    J Pathol; 1980 Nov; 132(3):255-62. PubMed ID: 7431161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.